Materials Map

Discover the materials research landscape. Find experts, partners, networks.

  • About
  • Privacy Policy
  • Legal Notice
  • Contact

The Materials Map is an open tool for improving networking and interdisciplinary exchange within materials research. It enables cross-database search for cooperation and network partners and discovering of the research landscape.

The dashboard provides detailed information about the selected scientist, e.g. publications. The dashboard can be filtered and shows the relationship to co-authors in different diagrams. In addition, a link is provided to find contact information.

×

Materials Map under construction

The Materials Map is still under development. In its current state, it is only based on one single data source and, thus, incomplete and contains duplicates. We are working on incorporating new open data sources like ORCID to improve the quality and the timeliness of our data. We will update Materials Map as soon as possible and kindly ask for your patience.

To Graph

1.080 Topics available

To Map

977 Locations available

693.932 PEOPLE
693.932 People People

693.932 People

Show results for 693.932 people that are selected by your search filters.

←

Page 1 of 27758

→
←

Page 1 of 0

→
PeopleLocationsStatistics
Naji, M.
  • 2
  • 13
  • 3
  • 2025
Motta, Antonella
  • 8
  • 52
  • 159
  • 2025
Aletan, Dirar
  • 1
  • 1
  • 0
  • 2025
Mohamed, Tarek
  • 1
  • 7
  • 2
  • 2025
Ertürk, Emre
  • 2
  • 3
  • 0
  • 2025
Taccardi, Nicola
  • 9
  • 81
  • 75
  • 2025
Kononenko, Denys
  • 1
  • 8
  • 2
  • 2025
Petrov, R. H.Madrid
  • 46
  • 125
  • 1k
  • 2025
Alshaaer, MazenBrussels
  • 17
  • 31
  • 172
  • 2025
Bih, L.
  • 15
  • 44
  • 145
  • 2025
Casati, R.
  • 31
  • 86
  • 661
  • 2025
Muller, Hermance
  • 1
  • 11
  • 0
  • 2025
Kočí, JanPrague
  • 28
  • 34
  • 209
  • 2025
Šuljagić, Marija
  • 10
  • 33
  • 43
  • 2025
Kalteremidou, Kalliopi-ArtemiBrussels
  • 14
  • 22
  • 158
  • 2025
Azam, Siraj
  • 1
  • 3
  • 2
  • 2025
Ospanova, Alyiya
  • 1
  • 6
  • 0
  • 2025
Blanpain, Bart
  • 568
  • 653
  • 13k
  • 2025
Ali, M. A.
  • 7
  • 75
  • 187
  • 2025
Popa, V.
  • 5
  • 12
  • 45
  • 2025
Rančić, M.
  • 2
  • 13
  • 0
  • 2025
Ollier, Nadège
  • 28
  • 75
  • 239
  • 2025
Azevedo, Nuno Monteiro
  • 4
  • 8
  • 25
  • 2025
Landes, Michael
  • 1
  • 9
  • 2
  • 2025
Rignanese, Gian-Marco
  • 15
  • 98
  • 805
  • 2025

Kasten, Georgia

  • Google
  • 7
  • 14
  • 401

Novo Nordisk (Denmark)

in Cooperation with on an Cooperation-Score of 37%

Topics

Publications (7/7 displayed)

  • 2019Process Optimization and Upscaling of Spray-Dried Drug-Amino acid Co-Amorphous Formulations22citations
  • 2019Co-former selection for co-amorphous drug-amino acid formulations96citations
  • 2018The Role of Glass Transition Temperatures in Coamorphous Drug-Amino Acid Formulations53citations
  • 2018In vitro and in vivo comparison between crystalline and co-amorphous salts of naproxen-arginine44citations
  • 2018The use of molecular descriptors in the development of co-amorphous formulations31citations
  • 2017Performance comparison between crystalline and co-amorphous salts of indomethacin-lysine66citations
  • 2016Development of a screening method for co-amorphous formulations of drugs and amino acids89citations

Places of action

Chart of shared publication
Paisana, Maria
1 / 1 shared
Rades, Thomas
7 / 107 shared
Grohganz, Holger
7 / 43 shared
Löbmann, Korbinian
6 / 49 shared
Duarte, Íris
1 / 1 shared
Kissi, Eric Ofosu
1 / 8 shared
Dengale, Swapnil
1 / 1 shared
Lobo, Lonita
1 / 1 shared
Rantanen, Jukka
1 / 43 shared
Poso, Antti
1 / 3 shared
Meng-Lund, Helena Marie Lindholm
1 / 3 shared
Pantsar, Tatu
1 / 1 shared
Jensen, Katrine Birgitte Tarp
1 / 4 shared
Nouri, Khatera
1 / 1 shared
Chart of publication period
2019
2018
2017
2016

Co-Authors (by relevance)

  • Paisana, Maria
  • Rades, Thomas
  • Grohganz, Holger
  • Löbmann, Korbinian
  • Duarte, Íris
  • Kissi, Eric Ofosu
  • Dengale, Swapnil
  • Lobo, Lonita
  • Rantanen, Jukka
  • Poso, Antti
  • Meng-Lund, Helena Marie Lindholm
  • Pantsar, Tatu
  • Jensen, Katrine Birgitte Tarp
  • Nouri, Khatera
OrganizationsLocationPeople

article

Co-former selection for co-amorphous drug-amino acid formulations

  • Rades, Thomas
  • Grohganz, Holger
  • Kasten, Georgia
  • Löbmann, Korbinian
Abstract

<p>We have previously developed a fast screening method on the ability of twenty amino acids (AA) to form co-amorphous formulations with six drugs upon ball milling. In this work, the potential advantages in physical stability and dissolution rate of the 36 successful co-amorphous formulations, compared to the pure amorphous drug, were further investigated. The physical stability of the formulations at dry conditions was assessed by X-ray powder diffraction (XRPD) and their thermal behavior by differential scanning calorimetry (DSC). In addition, the intrinsic dissolution rate (IDR) of all formulations was determined in phosphate buffer (10 mM, pH 6.8). Finally, all the co-amorphous formulations were summarized into different groups, according to the outcome of the co-formability, physical stability and dissolution rate screenings, and guidelines could be drawn for selection of co-formers for a new given drug: (i) For acidic drugs, basic AAs (arginine, histidine, and lysine) are good co-formers with respect to the three critical quality attributes: co-formability, physical stability and dissolution. High glass transition temperatures (Tg), physical stability for 1-2 years, and accelerated IDR were observed. (ii) For basic and neutral drugs, non-polar AAs with aromatic groups such as tryptophan (TRP) and phenylalanine (PHE) should be explored as first choice. These combinations presented high Tgs, which generally translated into good physical stability. The IDR of TRP- and PHE-based formulations were usually superior to the IDR of the pure amorphous drugs; (iii) Non-polar AAs with aliphatic structures such as leucine, isoleucine, methionine and valine did not provide an increase in Tg or IDR compared to the pure amorphous drug, and appear to be less feasible AAs for co-amorphous formulations.</p>

Topics
  • amorphous
  • glass
  • glass
  • laser emission spectroscopy
  • milling
  • thermogravimetry
  • glass transition temperature
  • differential scanning calorimetry
  • ball milling
  • ball milling
  • atomic absorpion spectrometry